Recent Warnings about Antihypertensive Drugs and Cancer Risk: Where Do They Come From?

Allegra Battistoni, Massimo Volpe

Research output: Contribution to journalReview articlepeer-review

1 Downloads (Pure)

Abstract

The recent decrease in mortality related to cardiovascular diseases has largely been due to the more effective treatment of cardiovascular risk factors and secondary prevention therapies. More people than ever are now on long-term medications. Hypertension, which is one of the most common cardiovascular risk factors, requires life-long treatment. Recent evidence has focused attention on the risk of cancer that may be associated with the long-term use of antihypertensive therapy. This article summarises available evidence surrounding three recent events in this setting. Even though this is a crucial patient safety issue, there are no conclusive answers at this time and further studies are required.

Original languageEnglish
Pages (from-to)e21
JournalEuropean Cardiology
Volume15
DOIs
Publication statusPublished - Feb 2020

Fingerprint

Dive into the research topics of 'Recent Warnings about Antihypertensive Drugs and Cancer Risk: Where Do They Come From?'. Together they form a unique fingerprint.

Cite this